Form 990 for tax year 2023
Filed by MARC LUSTGARTEN PANCREATIC CANCER FOUNDATION.
Totals
- Total revenue
- $22,749,028
- Total expenses
- $30,962,554
- Contributions and grants received
- $21,134,092
- Grants paid
- $21,875,654
- Program service revenue
- $0
- Investment income
- $1,266,888
- Other revenue
- $348,048
- Total assets, end of year
- $75,802,153
- Total liabilities, end of year
- $10,919,729
- Net assets or fund balances, end of year
- $64,882,424
- Program services expenses (Part IX)
- $25,620,369
- Management and general expenses
- $2,271,600
- Fundraising expenses
- $3,070,585
- Program service expenses (Part III)
- $25,620,369
Program services were 82.7% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.
Line items
Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.
Revenue
Part VIII, the statement of revenue.
-
1c · Fundraising events
$4,117,019
-
1f · All other contributions, gifts and grants
$17,017,073
-
1g · Noncash contributions included above
$213,772
-
3 · Investment income
total $1,917,224 · excluded $1,917,224
-
5 · Royalties
total $348,048 · excluded $348,048
-
7a · Gross sales of assets other than inventory
securities $165,090,346
-
7b · Less cost or other basis and sales expenses
securities $165,740,682
-
7c · Gain or loss
securities -$650,336
-
7d · Net gain or loss
total -$650,336 · excluded -$650,336
-
8a · Fundraising events: gross income
$47,396
-
8a · Fundraising events: contributions included on line 1c
$4,117,019
-
8b · Fundraising events: direct expenses
$47,396
-
8c · Net income from fundraising events
total $0
Functional expenses
Part IX, the statement of functional expenses.
-
1 · Grants to domestic organizations and governments
total $21,137,848 · program services $21,137,848
-
3 · Grants to foreign organizations and individuals
total $737,806 · program services $737,806
-
5 · Compensation of officers, directors and key employees
total $1,101,001 · program services $378,580 · management and general $576,558 · fundraising $145,863
-
7 · Other salaries and wages
total $2,734,725 · program services $1,364,998 · management and general $525,908 · fundraising $843,819
-
8 · Pension plan contributions
total $115,556 · program services $50,866 · management and general $33,256 · fundraising $31,434
-
9 · Other employee benefits
total $445,961 · program services $204,447 · management and general $133,406 · fundraising $108,108
-
10 · Payroll taxes
total $272,236 · program services $123,664 · management and general $72,983 · fundraising $75,589
-
11e · Fees: professional fundraising services
total $53,806 · fundraising $53,806
-
11f · Fees: investment management
total $291,213 · management and general $291,213
-
11g · Fees: other
total $832,242 · program services $443,040 · management and general $132,902 · fundraising $256,300
-
12 · Advertising and promotion
total $823,139 · program services $246,942 · management and general $82,314 · fundraising $493,883
-
14 · Information technology
total $490,606 · program services $196,242 · management and general $122,652 · fundraising $171,712
-
16 · Occupancy
total $259,711 · program services $103,884 · management and general $64,929 · fundraising $90,898
-
19 · Conferences, conventions and meetings
total $246,896 · program services $61,724 · management and general $37,034 · fundraising $148,138
-
22 · Depreciation, depletion and amortization
total $69,635 · program services $27,854 · management and general $17,409 · fundraising $24,372
-
23 · Insurance
total $50,924 · program services $20,370 · management and general $12,731 · fundraising $17,823
-
24a · Other expenses: DIRECT MAIL DESIGN & PR
total $1,044,206 · program services $522,104 · management and general $156,630 · fundraising $365,472
-
24b · Other expenses: BANK & CREDIT CARD FEES
total $248,428 · management and general $5,060 · fundraising $243,368
-
24e · All other expenses
total $6,615 · management and general $6,615
Balance sheet
Part X, book values.
-
1 · Cash, non-interest-bearing
beginning of year $3,731,289 · end of year $3,900,693
-
3 · Pledges and grants receivable
beginning of year $1,440,671 · end of year $2,663,022
-
9 · Prepaid expenses and deferred charges
beginning of year $190,010 · end of year $237,956
-
10a · Land, buildings and equipment: cost or other basis
$382,946
-
10b · Land, buildings and equipment: accumulated depreciation
$348,034
-
10c · Land, buildings and equipment, net
beginning of year $104,547 · end of year $34,912
-
11 · Investments: publicly traded securities
beginning of year $72,170,913 · end of year $68,965,570
-
15 · Other assets
beginning of year $923,045 · end of year $0
-
17 · Accounts payable and accrued expenses
beginning of year $889,012 · end of year $917,651
-
18 · Grants payable
beginning of year $7,382,067 · end of year $10,002,078
-
19 · Deferred revenue
beginning of year $30,000
-
25 · Other liabilities
beginning of year $1,002,106 · end of year $0
-
27 · Net assets without donor restrictions
beginning of year $68,173,573 · end of year $62,508,499
-
28 · Net assets with donor restrictions
beginning of year $1,083,717 · end of year $2,373,925
Mission and programs · 2023
Mission
THE LUSTGARTEN FOUNDATION IS BOLDY LEADING THE WAY THROUGH HOPE AND INNOVATION, TURNING FEAR INTO ACTION THROUGH EDUCATION AND EMPOWERMENT, AND ADVANCING THE BEST SCIENCE TO TRANSFORM PANCREATIC CANCER INTO A CURABLE DISEASE. SEE SCHEDULE OTHE LUSTGARTEN FOUNDATION IS BOLDY LEADING THE WAY THROUGH HOPE AND INNOVATION, TURNING FEAR INTO ACTION THROUGH EDUCATION AND EMPOWERMENT, AND ADVANCING THE BEST SCIENCE TO TRANSFORM PANCREATIC CANCER INTO A CURABLE DISEASE. THE FOUNDATION FOCUSES ON TRANSLATING OUR UNDERSTANDING OF THE UNDERLYING BIOLOGY OF PANCREATIC CANCER INTO CLINICAL APPLICATIONS TO CHANGE, EXTEND, AND ULTIMATELY SAVE PATIENTS' LIVES. IN FY24, THE FOUNDATION AWARDED $21.8 MILLION TO FUEL CUTTING-EDGE PANCREATIC CANCER RESEARCH, INCLUDING 10 NEW GRANTS TO RESEARCHERS AT SEVEN LEADING INSTITUTIONS. RESEARCH EFFORTS ARE CONCENTRATED ON THREE KEY PILLARS: EARLY DETECTION AND INTERCEPTION, DRUG DEVELOPMENT, AND PERSONALIZED MEDICINE.
Activities or mission (Part I)
THE LUSTGARTEN FOUNDATION IS THE LARGEST PRIVATE FUNDER OF PANCREATIC CANCER RESEARCH IN THE WORLD.THE LUSTGARTEN FOUNDATION IS THE LARGEST PRIVATE FUNDER OF PANCREATIC CANCER RESEARCH IN THE WORLD, FUNDING PREEMINENT PANCREATIC CANCER RESEARCHERS, DRIVING THE PURSUIT OF BOLD AND INNOVATIVE SCIENCE TOWARD EARLIER DETECTION AND BETTER TREATMENTS TO TRANSFORM PANCREATIC CANCER INTO A CURABLE DISEASE. THE FOUNDATION FUNDS RESEARCH WHERE CREATIVE RISKS YIELD HIGH REWARDS TO ACCELERATE AND EXPAND LIFE-SAVING TREATMENT OPTIONS. WE BELIEVE TIME IS EVERYTHING TO PATIENTS AND THEIR FAMILIES, AND THAT COMMUNITY IS POWER. LUSTGARTEN PROGRAMS AND EVENTS PROVIDE PEOPLE AFFECTED BY PANCREATIC CANCER A VOICE AND A PLACE TO CREATE HOPE, TOGETHER. THROUGH FY24, THE LUSTGARTEN FOUNDATION HAS INVESTED $287.2 MILLION IN PANCREATIC CANCER RESEARCH.
-
RESEARCH PROGRAM: THE LUSTGARTEN FOUNDATION'S MISSION IS TO ADVANCE THE BEST SCIENCE TO TRANSFORM PANCREATIC CANCER INTO A CURABLE DISEASE. 2024 MARKED THE FOUNDATION'S 26TH YEAR OF DRIVING PIONEERING PANCREATIC CANCER RESEARCH BREAKTHROUGHS, ACCELERATING PROGRESS FASTER THAN EVER BEFORE AND PROVIDING A MORE HOPEFUL FUTURE FOR ALL PATIENTS. SEE SCHEDULE O.
Expenses $23,621,306 · Grants $21,875,654
-
PUBLIC EDUCATION AND INFORMATION PROGRAM: THE LUSTGARTEN FOUNDATION IS THE LARGEST PRIVATE FUNDER OF PANCREATIC CANCER RESEARCH IN THE WORLD, FUNDING PREEMINENT PANCREATIC CANCER RESEARCHERS, DRIVING THE PURSUIT OF BOLD AND INNOVATIVE SCIENCE TOWARD EARLIER DETECTION AND BETTER TREATMENTS, AND TRANSFORMING PANCREATIC CANCER INTO A CURABLE DISEASE. THE FOUNDATION FUNDS RESEARCH WHERE CREATIVE RISKS YIELD HIGH REWARDS TO ACCELERATE AND EXPAND LIFE-SAVING TREATMENT OPTIONS. WE BELIEVE TIME IS EVERYTHING TO PATIENTS AND THEIR FAMILIES, AND THAT COMMUNITY IS POWER. LUSTGARTEN PROGRAMS AND EVENTS PROVIDE PEOPLE AFFECTED BY PANCREATIC CANCER A VOICE AND A PLACE TO CREATE HOPE, TOGETHER. SEE SCHEDULE O.
Expenses $1,241,565
-
PROFESSIONAL EDUCATION PROGRAM: PROFESSIONAL EDUCATION FOCUSED ON THE FOUNDATION'S SENIOR LEADERSHIP CONDUCTING HIGH-LEVEL MEETINGS WITH FUNDED SCIENTISTS AND DIRECTORS OF THE LABS PROGRAM SITES AND COLLABORATING ORGANIZATIONS, AS WELL AS ATTENDING/PRESENTING AT SCIENTIFIC MEETINGS. SEE SCHEDULE O.
Expenses $757,498
As filed on the 2023 return. The filer continues this part on Schedule O, which is not shown here.
Listed in Part VII
-
Andrew LustgartenANDREW LUSTGARTEN
CHAIRMAN
- Total calculated
- $0
- Hours/week
- 2
-
Charles F DolanCHARLES F DOLAN
CHAIRMAN EMERITUS (END 3/31/24)
- Total calculated
- $0
- Hours/week
- 2
-
Robert F VizzaROBERT F VIZZA
CHAIRMAN EMERITUS
- Total calculated
- $0
- Hours/week
- 2
-
Jennie FortunoffJENNIE FORTUNOFF
SECRETARY
- Total calculated
- $0
- Hours/week
- 2
-
Philip D'AmbrosioPHILIP D'AMBROSIO
TREASURER
- Total calculated
- $0
- Hours/week
- 2
-
James L DolanJAMES L DOLAN
VICE CHAIRMAN (END 3/31/24)
- Total calculated
- $0
- Hours/week
- 2
-
Adam SilverADAM SILVER
VICE CHAIRMAN
- Total calculated
- $0
- Hours/week
- 2
-
Sommer Bazuro PhDSOMMER BAZURO PHD
DIRECTOR
- Total calculated
- $0
- Hours/week
- 2
-
John H CobbJOHN H COBB
DIRECTOR
- Total calculated
- $0
- Hours/week
- 2
-
Jessica Lustgarten CourtemancheJESSICA LUSTGARTEN COURTEMANCHE
DIRECTOR
- Total calculated
- $0
- Hours/week
- 2
-
Quentin F DolanQUENTIN F DOLAN
TRUSTEE (END 3/31/24)
- Total calculated
- $0
- Hours/week
- 2
-
Marcia LustgartenMARCIA LUSTGARTEN
DIRECTOR
- Total calculated
- $0
- Hours/week
- 2
-
Sheila MahonySHEILA MAHONY
DIRECTOR
- Total calculated
- $0
- Hours/week
- 2
-
Charles R SchuelerCHARLES R SCHUELER
DIRECTOR
- Total calculated
- $0
- Hours/week
- 2
-
Willa ShalitWILLA SHALIT
DIRECTOR
- Total calculated
- $0
- Hours/week
- 2
-
Scott PenberthySCOTT PENBERTHY
DIRECTOR
- Total calculated
- $0
- Hours/week
- 2
-
Selwyn VickersSELWYN VICKERS
DIRECTOR
- Total calculated
- $0
- Hours/week
- 2
-
Aaron KantoffAARON KANTOFF
DIRECTOR (AS OF 6/7/2024)
- Total calculated
- $0
- Hours/week
- 2
-
Richard R Barakat MD MBARICHARD R BARAKAT MD MBA
DIRECTOR (AS OF 6/7/2024)
- Total calculated
- $0
- Hours/week
- 2
-
Linda TantawiLINDA TANTAWI
CEO
- Total calculated
- $520,974
- From this org
- $465,053
- From related orgs
- $0
- Other
- $55,921
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $351,303
- Bonus
- $113,750
- Other
- $0
- Deferred
- $19,188
- Nontaxable benefits
- $36,733
- Filer's total
- $520,974
-
Kerri KaplanKERRI KAPLAN
PRESIDENT
- Total calculated
- $377,993
- From this org
- $328,848
- From related orgs
- $0
- Other
- $49,145
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $260,993
- Bonus
- $67,855
- Other
- $0
- Deferred
- $4,750
- Nontaxable benefits
- $44,395
- Filer's total
- $377,993
-
Faisal JawaidFAISAL JAWAID
CFO
- Total calculated
- $305,001
- From this org
- $258,102
- From related orgs
- $0
- Other
- $46,899
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $205,602
- Bonus
- $52,500
- Other
- $0
- Deferred
- $11,631
- Nontaxable benefits
- $35,268
- Filer's total
- $305,001
-
Andrew RakemanANDREW RAKEMAN
VP RESEARCH
- Total calculated
- $311,037
- From this org
- $250,561
- From related orgs
- $0
- Other
- $60,476
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $207,561
- Bonus
- $43,000
- Other
- $0
- Deferred
- $12,511
- Nontaxable benefits
- $47,965
- Filer's total
- $311,037
-
Glen PeckGLEN PECK
SVP TECHNOLOGY & BUSINESS INTELLIGENCE
- Total calculated
- $321,848
- From this org
- $260,177
- From related orgs
- $0
- Other
- $61,671
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $214,777
- Bonus
- $45,400
- Other
- $0
- Deferred
- $13,052
- Nontaxable benefits
- $48,619
- Filer's total
- $321,848
-
Jaclyn P LymanJACLYN P LYMAN
HEAD CLINICAL RESEARCH & DEVELOPMENT
- Total calculated
- $198,227
- From this org
- $175,556
- From related orgs
- $0
- Other
- $22,671
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $166,931
- Bonus
- $8,625
- Other
- $0
- Deferred
- $6,723
- Nontaxable benefits
- $15,948
- Filer's total
- $198,227
-
Stephanie DergarabedianSTEPHANIE DERGARABEDIAN
NATIONAL DIRECTOR OF DEVELOPMENT
- Total calculated
- $204,176
- From this org
- $156,431
- From related orgs
- $0
- Other
- $47,745
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $139,583
- Bonus
- $16,848
- Other
- $0
- Deferred
- $8,176
- Nontaxable benefits
- $39,569
- Filer's total
- $204,176
-
Susan M JacobsonSUSAN M JACOBSON
DIRECTOR EXTERNAL & COMMUNITY RELATIONS
- Total calculated
- $193,819
- From this org
- $155,304
- From related orgs
- $0
- Other
- $38,515
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $138,504
- Bonus
- $16,800
- Other
- $0
- Deferred
- $8,864
- Nontaxable benefits
- $29,651
- Filer's total
- $193,819
Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us.
Schedule J
Answered yes
- 3 · Form 990 of other organizations
- 3 · Compensation survey or study
- 3 · Approval by the board or compensation committee
- 4b · Supplemental nonqualified retirement plan
- 7 · Other non-fixed payments
Answered no
- 4a · Severance or change-of-control payment
- 4c · Equity-based compensation arrangement
- 5a · Pay contingent on this organization's revenues
- 5b · Pay contingent on a related organization's revenues
- 6a · Pay contingent on this organization's net earnings
- 6b · Pay contingent on a related organization's net earnings
- 8 · Paid under the initial-contract exception
The filer's explanations (Part III)
- PART I, LINE 4B:
- NONQUALIFIED RETIREMENT PLAN LINDA TANTAWI, CEO, PARTICIPATES IN A SUPPLEMENTAL NONQUALIFIED RETIREMENTPLAN, AND $1,150 OF DEFERRED COMPENSATION RELATED TO THE PLAN IS REPORTED ON SCHEDULE J, PART II, COLUMN (C).
- PART I, LINE 7:
- NONFIXED PAYMENTS IN 2023, OFFICERS AND EMPLOYEES RECEIVED NONFIXED DISCRETIONARY BONUSES AS REPORTED ON SCHEDULE J, PART II, COLUMN (B)(II).
Part I's answers as filed. A line not listed was left unanswered; on lines 1a and 3 that means the box was not checked.
Grants on this return
-
$8,784,577
PANCREATIC CANCER RESEARCH
-
$2,823,857
PANCREATIC CANCER RESEARCH
-
$1,987,065
PANCREATIC CANCER RESEARCH
-
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
$1,915,072
PANCREATIC CANCER RESEARCH
-
NYU GROSSMAN SCHOOL OF MEDICINE
$1,143,584
PANCREATIC CANCER RESEARCH
-
THE SALK INSTITUTE FOR BIOLOGICAL STUDIES
$1,000,000
PANCREATIC CANCER RESEARCH
-
PANCREATIC CANCER RESEARCH
-
PANCREATIC CANCER RESEARCH
-
MASSACHUSETTES GENERAL HOSPITAL
$500,000
PANCREATIC CANCER RESEARCH
-
$351,000
PANCREATIC CANCER RESEARCH
The 10 largest by cash amount. The API serves every itemized grant.
Provenance
- Return type
- form_990
- Tax year
- 2023
- Filed
- 10 February 2025
- IRS schema version
- 2023v6.0
- Source object
- 202530429349300308
Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.
The source document this was parsed from is served over the API, which is where bulk and document access live.